Skip to content

A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02140892
Enrollment
75
Registered
2014-05-16
Start date
2014-07-31
Completion date
2015-12-31
Last updated
2014-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Bronchitis, Chronic Obstructive Pulmonary Disease

Brief summary

One of the main goals of the respiratory physical therapy is to help people who are suffering from accumulating of secretions in their airways and lungs. Chronic Obstructive Pulmonary Disease (COPD) patients are often hospitalized with an Acute Exacerbation of their medical condition. Those patients usually get only the standard medical care during the acute phase and don't get respiratory physical therapy treatment. The study's main aim is to investigate if respiratory physical therapy treatment in addition to standard medical care during the acute phase, can improve the respiratory and medical condition and reduce hospitalization stay. In order to do so we will compare three groups of COPD patients during acute exacerbation; two groups will get one out of two respiratory physical therapy techniques; manually or Intrapulmonary Percussive Ventilator (IPV) in addition to standard medical care and the third group will get standard medical care alone.

Interventions

PROCEDURErespiratory physical therapy manual technique- Autogenic Drainage
DEVICErespiratory physical therapy technique- IPV

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of Acute Exacerbation of COPD or Acute Exacerbation of Chronic Bronchitis * Respiratory Rate\>25 * PaCO2\> 45 mmHg * 7.35 \< PH \< 7.38

Exclusion criteria

* intubation * apnea * glasgow coma scale \< 8 * pneumothorax * FEV1 \< 50% predicted * Ischemic Hearth Disease

Design outcomes

Primary

MeasureTime frame
length of stay in the hospitalup to three months

Contacts

Primary ContactYaakov (kobi) Dagan, Msc.
kobi.dagan@sheba.health.gov.il0523694979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026